Analysis questions experimental procedure’s blood-pressure-lowering potential
An analysis of an experimental procedure called “renal denervation” — used to try and reduce high blood pressure — casts doubt on how well the procedure works.
According to a report on the new analysis, which is publishing online this week in the journal Heart, renal denervation may only lower blood pressure by about one-third of the amount reported in earlier studies. Renal denervation therapy is not currently approved by the Food and Drug Administration, although trials are underway in the United States to evaluate the procedure for use in patients with high blood pressure that is difficult to control.
During renal denervation, physicians thread a catheter to the arteries leading to the kidneys, where it delivers radio waves to deaden part of the nerves lining the arteries. Those nerves are believed to contribute to high blood pressure.
Despite the potential differences in the reported impact of renal denervation, the therapy is still promising, said Robert Bonow, past president of the American Heart Association and Goldberg Distinguished Professor of Cardiology at Northwestern University Feinberg School of Medicine.
“Any drug or device, new or old, that lowers blood pressure is potentially very important in lowering the risk of future strokes and heart attacks. In patients whose blood pressure is difficult to control with medications, this new approach may be a significant step forward,” Dr. Bonow said.
“However, for the great majority of patients with this very common health problem, the keys will be following their physicians’ advice about medication adherence and lifestyle. It should not be overlooked that exercise, weight control, and diet are very effective means to reduce blood pressure and should be the foundation upon which medication and/or device therapies are added if necessary,” Dr. Bonow said.
For more information:
Stories available for linking, quoting, excerpting, reprinting
Stories appearing on blog.heart.org under the "By American Heart Association News" byline are available for linking, quoting, excerpting and reprinting. Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, to link to, quote, excerpt or reprint from these stories in any medium as long as no text is altered and proper attribution is made to the American Heart Association. Additional conditions may apply to the use of these stories in printed materials.
American Heart Association additional conditions for linking, quoting, excerpting, reprinting stories in print media
- A credit line of American Heart Association News must be prominently placed on the page in which the American Heart Association materials appear.
- The American Heart Association logo and service marks may only be used if they appear on the materials requested.
- Stories reprinted may be edited for length, but no other deletions, alterations or other changes may be made without the prior written consent of the American Heart Association.
- Artwork labeled "American Heart Association" may be reprinted, but other artwork may not. For artwork permission questions, contact firstname.lastname@example.org
- Stories reprinted may not be placed adjacent to any advertisement, photo, graphic or other content that could be considered inappropriate by the American Heart Association. For questions about whether content is inappropriate, contact email@example.com.
- Stories may not be displayed in any way that gives the appearance that the American Heart Association endorses (implied or otherwise) or is affiliated with any product, service or company.